Showing results (61-70 of 776) with videos related to
Sort By:
Pageof 78
Oncogene|December 22, 1999
Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin BP Smart, E B Lane, D P Lane, et al.Oncogene|August 29, 2007
Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeastD Grochova, J Vankova, J Damborsky, et al.Cell Cycle (Georgetown, Tex.)|March 20, 2015
TAp63gamma is required for the late stages of myogenesisS Cefalù, A M Lena, B Vojtesek, et al.The Biochemical Journal|August 5, 1999
Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancersA L Craig, L Burch, B Vojtesek, et al.Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 13, 2013
A combined immunoprecipitation and mass spectrometric approach to determine deltaNp63-interacting partnersL Hernychova, M Nekulova, D Potesil, et al.Canadian Journal of Physiology and Pharmacology|August 1, 1984
The 2-deoxyglucose uptake method as a first screen for neurotoxic compoundsP Muller, L MartinPsychopharmacology|December 15, 1978
Dopaminergic supersensitivity after neuroleptics: time-course and specificityP Muller, P SeemanEuropean Journal of Pharmacology|April 15, 1979
Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimeticsP Muller, P SeemanKlinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 23, 2008
[Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method]E Michalová, A Poprach, I Nemecková, et al.Pageof 78